Obesity and Diabetes

Patients with type 2 diabetes are obese, and the global epidemic of obesity, its incidence and prevalence of type 2 diabetes over the past 20 years has given glance of diabetes in recent times. Excess weight is the main risk factor for type 2 diabetes, most of the obese individuals do not develop type 2 diabetes. Recent studies have identified relation between obesity and type 2 diabetes as it involves proinflammatory cytokines (tumor necrosis factor and interleukin-6), insulin resistance, deranged fatty acid metabolism, and cellular processes such as mitochondrial dysfunction and endoplasmic reticulum stress. These interactions are complex, and each of the are unclearly defined. Further genetic studies may elucidate additional  pathophysiological pathways for obesity and diabetes and identify promising new treatment targets. As physicians frequently prescribe glucose lowering medications associated with weight gain, as it results in  glycemic control and body weight and  current therapeutic options need more consideration. The issue is particularly concentrating on the evidence that even modest weight reduction whether through lifestyle or behavioral interventions, obesity medications, or bariatric surgery can improve glycemic control and reduce diabetes risk.

  • Type-2 Diabetes
  • Nutritional Therapy
  • Role of Hyperinsulinism
  • Obesity and Adipose Tissue Biology
  • Normal Insulin Sensitivity
  • Obesity Dependent Diabetes: Treatment

Related Conference of Obesity and Diabetes

Oct 23-24, 2017

14th Global Obesity Meeting

Dubai, UAE
October 30- 31, 2017

15th International Conference on Obesity Medicine

Bangkok, Thailand
May 17- 18, 2018

19th World Obesity Congress

September 13-14, 2018

14th Euro Obesity and Endocrinology Congress

London, UK
Oct 29-30, 2018

World Obesity Congress

October 22-23, 2018

17th World Congress on Obesity & Nutrition

Osaka, Japan

Obesity and Diabetes Conference Speakers

Recommended Sessions

Related Journals

Are you interested in